Table 1.
Demographics and clinical characteristics of the study subjects
| Randomized (n = 44) | p-Value | |
|---|---|---|
| Variables | Experimental/Control Group | |
| (n = 22)/(n = 22) | ||
| Age (years) | 63.86 ± 4.57/62.32 ± 4.61 | 0.936 |
| Gender | ||
| Female | 9 (41%)/10 (45.45%) | |
| Male | 13 (59%)/12 (54.55%) | |
| Height (cm) | 160.36 ± 3.70/164.36 ± 2.68 | 0.397 |
| Weight (kg) | 59.59 ± 4.90/60.73 ± 5.43 | 0.71 |
| Disease duration (years) | 6.23 ± 1.85/6.55 ± 1.68 | 0.887 |
| Age at onset of PD | 56.00 ± 4.06/55.50 ± 4.53 | 0.912 |
| Age at diagnosis of PD | 59.55 ± 3.91/60.05 ± 4.13 | 0.443 |
| H&Y Stage | 2.11 ± 0.74/2.25 ± 0.67 | 0.72 |
| MMSE | 26.41 ± 1.91/25.27 ± 4.38 | 0.029 |
| UPDRS-III baseline | 32.45 ± 3.98/31.86 ± 4.62 | 0.742 |
PD; Parkinson’s disease, MMSE; Mini mental state examination, H&Y: Hoehn and Yahr Stage.